Skip to content
MARKETS / BALCAO / FCHS
BALCAO · SERVICES-MEDICAL LABORATORIES

First Choice Healthcare Solutions, Inc. FCHS

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$-7.0M
In brief

What this company does

Although we still provide rehabilitative services on a limited basis, such as physical therapy, as part of our go-forward strategy, we will terminate all of our remaining legacy orthopedic and physical therapy services and focus the company resources on our strategy of building and operating medical functional health and wellness clinics. The first wholly owned subsidiary, FCID Medical, Inc. (“FCID Medical”) is the subsidiary under which we own and operate First Choice Medical Group of Brevard, LLC, (“FCMG”), our original medical services practice. The second wholly owned subsidiary, The Good Clinic Properties, LLC is the subsidiary under which we have leased clinic facilities. Our go forward strategy will be executed using a corporate structure of centralized management services designated as Leading Primary Care, Inc. with three operating subsidiaries, Live Well Medical Group (comprised of the primary care clinic locations nationally), The Good Clinic Properties, Inc. (which holds leases on all physical clinic locations), and Live Well Drugstore, Inc. (comprised of our current and future compounding pharmacy operations). Historically, we offered fully integrated Orthopedic services, delivering diagnostics, surgery and treatment services.

Written from the business description in First Choice Healthcare Solutions, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 11 March 2026. Every sentence was checked against that document before publication.

Growth
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2013 · Revenue 1.0 · Net income -4.7
0.5M1.0M-2.5M-5.0M2010201220142016202220242025
Compound annual growth
−6.0%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
Operating margin Net margin
FY2013 · Operating -93.3% · Net -448.7%
-200%-400%2010201220142016202220242025
ROE
FY2017 · ROE 31.2%
50%100%2010201220142016202220242025

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2023 · FCF -6.9
-2.5M-5.0M2010201220142016202220242025

Total assetsUSD 4.0M
EquityUSD -39.5M
CashUSD 5,896.00
Current ratio0.00×

Equity funds -977% of total assets.

The 12-year record
12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220172016201520142013201220112010
Revenue $B········0.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.00.0
EBITDA $B−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.00.0−0.0·
Income tax $B·0.0····0.00.00.0−0.0−0.00.0
Net income $B−0.0−0.0−0.0−0.00.00.0−0.0−0.0−0.0−0.0−0.00.0
Free cash flow $B··−0.0−0.0−0.0−0.00.0−0.0−0.0−0.00.0·
EPS, diluted $−0.21−0.12−0.25−0.300.150.37−0.17−0.14−0.35−0.07−0.530.00
Dividend / sh $············
Payout %············
ROE %····31.2114.2······
Shares out B0.030.030.030.030.030.020.020.020.020.010.010.05

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 13 of 19 fiscal years. 28 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Medical Laboratories
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2010

Share this section

Download image